Szegedi V - Search Results

1

Tianeptine potentiates AMPA receptors by activating CaMKII and PKA via the p38, p42/44 MAPK and JNK pathways.

Szegedi V, Juhász G, Zhang X, Barkóczi B, Qi H, Madeira A, Kapus G, Svenningsson P, Spedding M, Penke B. Szegedi V, et al. Neurochem Int. 2011 Dec;59(8):1109-22. doi: 10.1016/j.neuint.2011.10.008. Epub 2011 Oct 25. Neurochem Int. 2011. PMID: 22056552

2

Enhancement of NMDA responses by beta-amyloid peptides in the hippocampus in vivo.

Molnár Z, Soós K, Lengyel I, Penke B, Szegedi V, Budai D. Molnár Z, et al. Among authors: szegedi v. Neuroreport. 2004 Jul 19;15(10):1649-52. doi: 10.1097/01.wnr.0000134471.06244.d2. Neuroreport. 2004. PMID: 15232300

3

Pentapeptides derived from Abeta 1-42 protect neurons from the modulatory effect of Abeta fibrils--an in vitro and in vivo electrophysiological study.

Szegedi V, Fülöp L, Farkas T, Rózsa E, Robotka H, Kis Z, Penke Z, Horváth S, Molnár Z, Datki Z, Soós K, Toldi J, Budai D, Zarándi M, Penke B. Szegedi V, et al. Neurobiol Dis. 2005 Apr;18(3):499-508. doi: 10.1016/j.nbd.2004.12.008. Neurobiol Dis. 2005. PMID: 15755677

4

Divergent effects of Abeta1-42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo.

Szegedi V, Juhász G, Budai D, Penke B. Szegedi V, et al. Brain Res. 2005 Nov 16;1062(1-2):120-6. doi: 10.1016/j.brainres.2005.09.014. Epub 2005 Oct 24. Brain Res. 2005. PMID: 16248989

5

Endomorphin-2, an endogenous tetrapeptide, protects against Abeta1-42 in vitro and in vivo.

Szegedi V, Juhász G, Rózsa E, Juhász-Vedres G, Datki Z, Fülöp L, Bozsó Z, Lakatos A, Laczkó I, Farkas T, Kis Z, Tóth G, Soós K, Zarándi M, Budai D, Toldi J, Penke B. Szegedi V, et al. FASEB J. 2006 Jun;20(8):1191-3. doi: 10.1096/fj.05-4891fje. Epub 2006 Apr 24. FASEB J. 2006. PMID: 16636106

6

Differences between normal and alpha-synuclein overexpressing SH-SY5Y neuroblastoma cells after Abeta(1-42) and NAC treatment.

Hunya A, Földi I, Szegedi V, Soós K, Zarándi M, Szabó A, Zádori D, Penke B, Datki ZL. Hunya A, et al. Among authors: szegedi v. Brain Res Bull. 2008 Mar 28;75(5):648-54. doi: 10.1016/j.brainresbull.2007.10.035. Epub 2007 Nov 20. Brain Res Bull. 2008. PMID: 18355641

7

Integrin activation modulates NMDA and AMPA receptor function of CA1 cells in a dose-related fashion in vivo.

Juhász G, Vass G, Bozsó Z, Budai D, Penke B, Szegedi V. Juhász G, et al. Among authors: szegedi v. Brain Res. 2008 Oct 3;1233:20-6. doi: 10.1016/j.brainres.2008.05.032. Epub 2008 May 21. Brain Res. 2008. PMID: 18762286

8

An intraperitoneally administered pentapeptide protects against Abeta (1-42) induced neuronal excitation in vivo.

Juhász G, Márki A, Vass G, Fülöp L, Budai D, Penke B, Falkay G, Szegedi V. Juhász G, et al. Among authors: szegedi v. J Alzheimers Dis. 2009;16(1):189-96. doi: 10.3233/JAD-2009-0947. J Alzheimers Dis. 2009. PMID: 19158435

9

Controlled in situ preparation of A beta(1-42) oligomers from the isopeptide "iso-A beta(1-42)", physicochemical and biological characterization.

Bozso Z, Penke B, Simon D, Laczkó I, Juhász G, Szegedi V, Kasza A, Soós K, Hetényi A, Wéber E, Tóháti H, Csete M, Zarándi M, Fülöp L. Bozso Z, et al. Among authors: szegedi v. Peptides. 2010 Feb;31(2):248-56. doi: 10.1016/j.peptides.2009.12.001. Epub 2009 Dec 6. Peptides. 2010. PMID: 19995586

10

Fibrillar Abeta (1-42) enhances NMDA receptor sensitivity via the integrin signaling pathway.

Uhász GJ, Barkóczi B, Vass G, Datki Z, Hunya A, Fülöp L, Budai D, Penke B, Szegedi V. Uhász GJ, et al. Among authors: szegedi v. J Alzheimers Dis. 2010;19(3):1055-67. doi: 10.3233/JAD-2009-1301. J Alzheimers Dis. 2010. PMID: 20157259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters